Expression of Fc receptors for IgE (FcER) 
Introduction
An increasing body of data suggests that immunoglobulin Ig isotypes involved in antibody responses are regulated by cells expressing Fc receptors for specific isotypes (1) (2) (3) . T cells expressing receptors for IgE (FcER)' or IgA (FcAR) have been detected and induced on human peripheral blood lymphocytes (4) (5) (6) (7) (8) . Additionally we reported that T cells exposed to immune complexes (IC) formed by IgE and anti-IgE (IgE-IC) were activated, presumably through FcER, to specifically inhibit IgE synthesis (9) . However, the T cell fractions employed in those studies were isolated by sheep red blood cell (E) roset- ting methods and thus contained natural killer (NK) cells which bear low affinity E receptors (10) . Human NK cells are known to express Fc gamma receptors (FcGR) (11) while FcER or FcAR on human NK cells have not been well defined. It has been reported that some NK cells express the FcER both in mice and human (12, 13) . It has also been reported that human NK cells were able to produce B cell differentiation factors (BCDF) (14) .
We have previously shown that human NK cells are capable of inhibiting, via a cytolytic mechanism, ongoing IgE synthesis from the human IgE myeloma cell line (U266/AF-10) (15) . This inhibition could be reversed by incubating the NK cells with IgE-IC. The apparent reversal of inhibition was, in fact, due to enhancement of IgE synthesis from the remaining non-lysed AF-10 cells, induced by IgE-IC stimulated NK cells, rather than decreased NK cytotoxicity. On 
Methods
Cell separation. Human mononuclear cells were isolated from heparinized venous blood of normal volunteers or patients with various disturbances of circulating Ig levels by buoyant density centrifugation on Ficoll-Hypaque. Usually 200 ml of blood were obtained although when NKH-1+ cells were separated into CD3+ or CD3-populations, 300-400 ml were taken. Sheep red blood cell binding cells (T cells) were purified from the mononuclear cells by the 2-aminoethylisothiouronium bromide (AET; Sigma Chemical Co., St. Louis, MO)-treated E rosette technique (16, 17) .
Patients. Blood samples were obtained from the following patients. Hyper-IgE immunodeficiency (n = 3, serum IgE 24,000, 44,000, and 46,200 ng/ml; IgA levels normal), atopic dermatitis (n = 3, serum IgE 1,540, 5,940 and 24,200 ng/ml; IgA levels normal), IgA myeloma (n deficiency (n = 2, IgA < 5 mg/dl, IgE 8 and 24 ng/ml), dysgammaglobulinemia type I (n = 1, IgA < 5 mg/dl, IgE < 80 pg/ml, IgM 1,000 mg/dl), common variable immunodeficiency (CVI, n = 3, IgA < 5 mg/dl, IgE < 80 pg/ml). Serum IgE was measured by our radioimmunoassay (lower limit 80 pg/ml) (9) .
Purification ofNK cells. NK cells were purified from T cells by a modification of immune adherence as described (15, 18 (26, 27 (Fig. 1 A) or FcAR+ (Fig. 1 B) Fig. 4 A, supernatants from FcER+ NK cells enhanced IgE synthesis significantly (P < 0.01), while supernatants from FcER-NK cells failed to do so. In contrast, supernatants from both populations (< 1% FcAR+) failed to enhance IgA synthesis and enhanced IgG synthesis equally. Conversely, IgA synthesis was enhanced (P < 0.01) by super- (n=3)
IgA-IC (Fig. 4) .
It has been reported that supernatants from FcER+ T cell or B cell lines contain IgE binding factors that can regulate IgE synthesis in an isotype-specific fashion (6, 41 (Fig. 4) . The FcER on B cells (now known to be the CD23 antigen) (43) is induced by (44) and is a receptor for a low molecular B cell growth factor (45) though whether it functions as a growth factor receptor on NK cells is unknown. Thus it is not surprising that supernatants from FcER+ B cell lines contain B cell growth factor(s) (46) . These IgE binding factors that presumably represent fragments ofthe FcER, from FcER+ B or T cell lines, also affect IgE production from in vitro or in vivo IgE secreting cells (41, 47 (Fig. 4) . IL-4 has been reported to induce FcER on B cells and enhance IgE and IgGl synthesis while relatively inhibiting other isotypes (44, 48 
